Globus Medical stock downgraded to “sell” by Goldman Sachs: 3 points

Goldman Sachs downgraded Globus Medical stock to a “sell” rating, according to a report by The Market Digest.

Advertisement

Here are three points:

 

1. The investment firm previously rated Globus Medical stock as “neutral.”

 

2. The company has a market cap of $2.8 billion.

 

3. On May 13, Globus Medical opened for trading at $23.40 and ended the session at $23.53.

 

More articles on devices:
Misonix revenue reaches $5.4M in Q3: 8 highlights
RTI Surgical outlines why stockholders should elect its director nominees on WHITE proxy card: 5 points
Stryker, Smith & Nephew, K2M & more: 18 key notes

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.